Cancer & Oncology
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader, such as GoogleReader, or to display this data on your own website or blog. 
Subscribe to this data using MyMedWorm.
Subscribe to this data using GoogleReader.
Subscribe to this data using Bloglines.
Subscribe to this data using MyYahoo.
Get the very latest Swine Flu news via the MedWorm Swine Flu RSS news feed - updated hourly from thousands of authoritative health and news sources.
This page shows you the most recent publications within this specialty of the MedWorm directory.
Analysis of Factors Influencing Outcome in Patients With In-Transit Malignant Melanoma Undergoing Isolated Limb Perfusion Using Modern Treatment Parameters
Email this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
In this single-center study of 91 patients with stage III in-transit extremity melanoma, operative isolated limb perfusion (ILP) was associated with high response rates and long-term survival. ILP treatment...
Access... (Source: OncologySTAT Journal Scans)
Source: OncologySTAT Journal Scans - November 21, 2009 Category: Cancer & Oncology Source Type: journals
ACOG Recommends Changes in Cervical ScreeningEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
The American College of Obstetricians and Gynecologists announced Nov. 20 that it is now recommending delaying the start of cervical cancer screening until age 21 and then screening most patients every... (Source: OncologySTAT Latest News)
Source: OncologySTAT Latest News - November 21, 2009 Category: Cancer & Oncology Source Type: news
IL-6 overexpression plus androgen withdrawal could reduce prostate cancer growthEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Overexpression of interleukin-6 in prostate cancer cells enhances their sensitivity to androgen withdrawal both in vitro and in vivo, say researchers who claim their study is the first to demonstrate the association. (Source: MedWire News - Prostate Cancer)
Source: MedWire News - Prostate Cancer - November 21, 2009 Category: Cancer & Oncology Source Type: news
IL-6 overexpression plus androgen withdrawal could reduce prostate cancer growthEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Overexpression of interleukin-6 in prostate cancer cells enhances their sensitivity to androgen withdrawal both in vitro and in vivo, say researchers who claim their study is the first to demonstrate the association. (Source: MedWire News - Oncology)
Source: MedWire News - Oncology - November 21, 2009 Category: Cancer & Oncology Source Type: news
Use of Sorafenib for advanced hepatocellular carcinomaEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
NICE has issued a final appraisal determination (FAD) on the... (Source: Cancer Plan Newsfeed)
Source: Cancer Plan Newsfeed - November 21, 2009 Category: Cancer & Oncology Source Type: organizations
NICE consultationsEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
NICE has issued the following consultation documents:
-... (Source: Cancer Plan Newsfeed)
Source: Cancer Plan Newsfeed - November 21, 2009 Category: Cancer & Oncology Source Type: organizations
Alcohol intake and CHD incidenceEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Research published in the journal 'Heart' set out to analyse... (Source: Cancer Plan Newsfeed)
Source: Cancer Plan Newsfeed - November 21, 2009 Category: Cancer & Oncology Source Type: organizations
Updated regimens on par with standard therapy in diffuse large B-cell lymphomaEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Researchers are exploring ways to manipulate rituximab (Rituxan) when added to the current standard therapy for diffuse large B-cell lymphoma, specifically shortening the number of treatment days. Preliminary results of a phase III trial showed that rituximab plus CHOP over a 14-day cycle achieved similar response rates and comparable toxicity compared to CHOP on a 21-day cycle in newly diagnosed patients. (Source: Cancer Network)
Source: Cancer Network - November 21, 2009 Category: Cancer & Oncology Source Type: info
Robot-Assisted SurgeryEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Robot-assisted prostate surgery is a relatively new option for treating prostate cancer. This surgery is of great interest to men with prostate cancer as well as the general public, but there are plenty of misconceptions about it. Learn what this procedure really entails here. (Source: About.com Prostate Cancer)
Source: About.com Prostate Cancer - November 21, 2009 Category: Cancer & Oncology Tags: health Source Type: consumer
Latissimus DorsiEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
The latissimus dorsi is a broad, triangular flat muscle on your back. It is connected to bones in your spine, shoulder and arms. (Source: About.com Breast Cancer)
Source: About.com Breast Cancer - November 21, 2009 Category: Cancer & Oncology Authors: breastcancer.guide at about.com Tags: health Source Type: consumer
Alexander disease: An important mimicker of focal brainstem gliomaEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
No Abstract. (Source: Pediatric Blood and Cancer)
Source: Pediatric Blood and Cancer - November 21, 2009 Category: Cancer & Oncology Authors: Stefan Ring, Herwig Lackner, Christian Urban, Michaela Brunner-Krainz, Barbara Plecko-Startinig Source Type: journals
ErratumEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
No abstract. (Source: Cancer)
Source: Cancer - November 21, 2009 Category: Cancer & Oncology Source Type: journals
Impairment of mitochondrial respiration in mouse fibroblasts by oncogenic H-RAS(Q61L).Email this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
A common metabolic change in cancer is the acquisition of glycolytic phenotypes. Increased expression of glycolytic enzymes is considered as one contributing factor. The role of mitochondrial defects in acquisition of glycolytic phenotypes has been postulated but remains controversial. Here we show that functional defects in mitochondrial respiration could be induced by oncogenic H-Ras(Q61L) transformation, even though the mitochondrial contents or mass was not reduced in the transformed cells. First, mitochondrial respiration, as measured by mitochondrial oxygen consumption, was suppressed in NIH-3T3 cells transformed...
Source: Cancer Biology and Therapy - November 20, 2009 Category: Cancer & Oncology Authors: Yang D, Wang MT, Tang Y, Chen Y, Jiang H, Jones TT, Rao K, Brewer GJ, Singh KK, Nie D Tags: Cancer Biol Ther Source Type: journals
Exposure to formaldehyde linked to increased risk for cancer-related deathEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
(Source: HemOncToday.com)
Source: HemOncToday.com - November 20, 2009 Category: Cancer & Oncology Source Type: info
Blocking Tissue Stiffening Enzyme Could Be Key To Preventing Aggressive CancersEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
A team of scientists from the US and the UK have shown that blocking an enzyme called lysyl oxidase (LOX) that causes tissue to stiffen reduces the likelihood of abnormal but non-malignant breast tissue turning into tumors, suggesting that LOX and similar enzymes could be new targets for effective anti-cancer drug therapies. (Source: Breast Cancer News From Medical News Today)
Source: Breast Cancer News From Medical News Today - November 20, 2009 Category: Cancer & Oncology Tags: Breast Cancer Source Type: news
ACOG Revises Cervical Cancer Screening GuidelinesEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
The
American College of Obstetricians and Gynecologists (ACOG) has just issued new cervical cancer screening guidelines. (Source: American Cancer Society :: News and Features)
Source: American Cancer Society :: News and Features - November 20, 2009 Category: Cancer & Oncology Source Type: organizations
Cervical cancer screening recommended every two years for women between 21 and 29Email this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
(Source: HemOncToday.com)
Source: HemOncToday.com - November 20, 2009 Category: Cancer & Oncology Source Type: info
CYP2D6 predicted treatment outcome in tamoxifen-treated metastatic breast cancerEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
(Source: HemOncToday.com)
Source: HemOncToday.com - November 20, 2009 Category: Cancer & Oncology Source Type: info
House passes bill to repeal and replace the sustainable growth rate formulaEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
(Source: HemOncToday.com)
Source: HemOncToday.com - November 20, 2009 Category: Cancer & Oncology Source Type: info
Stopping Tissue Stiffening Is Key To Preventing Aggressive CancersEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Scientists have identified an enzyme that is crucial for turning abnormal but non-malignant breast tissue into tumours, according to a study published today in Cell online. Blocking the enzyme lysyl oxidase (LOX) reduced the chance a tumour would form, and also meant tumours that did develop were smaller and less aggressive. (Source: Cancer / Oncology News From Medical News Today)
Source: Cancer / Oncology News From Medical News Today - November 20, 2009 Category: Cancer & Oncology Tags: Cancer / Oncology Source Type: news
Electronic Pages AbstractEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
(Source: Oral Oncology)
Source: Oral Oncology - November 20, 2009 Category: Cancer & Oncology Tags: Printed Pages (pp. 1005-1078) Source Type: journals
Editorial Board/Aims & ScopeEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
(Source: Oral Oncology)
Source: Oral Oncology - November 20, 2009 Category: Cancer & Oncology Source Type: journals
Morphine Supports Tumor Cell Proliferation and AngiogenesisEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Morphine and other opiate-based painkillers appear to foster the growth of cancer cells. Two new studies, conducted in cell lines and in mice, add evidence to this previously reported observation. Morphine... (Source: OncologySTAT What Patients Are Reading)
Source: OncologySTAT What Patients Are Reading - November 20, 2009 Category: Cancer & Oncology Source Type: info
AS feasible for favorable-risk prostate cancer patientsEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Active surveillance is a feasible treatment option for men with favorable-risk prostate cancer, and for those who are over 70 years old with intermediate-risk disease, say Canadian researchers. (Source: MedWire News - Prostate Cancer)
Source: MedWire News - Prostate Cancer - November 20, 2009 Category: Cancer & Oncology Source Type: news
Lapatinib monotherapy feasible for HER2-positive metastatic breast cancerEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Lapatinib monotherapy is an effective treatment for patients with human epidermal growth factor receptor 2-positive advanced or metastatic breast cancer that has relapsed after trastuzumab treatment, Japanese research suggests. (Source: MedWire News - Oncology)
Source: MedWire News - Oncology - November 20, 2009 Category: Cancer & Oncology Source Type: news
Lapatinib monotherapy feasible for HER2-positive metastatic breast cancerEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Lapatinib monotherapy is an effective treatment for patients with human epidermal growth factor receptor 2-positive advanced or metastatic breast cancer that has relapsed after trastuzumab treatment, Japanese research suggests. (Source: MedWire News - Breast Cancer)
Source: MedWire News - Breast Cancer - November 20, 2009 Category: Cancer & Oncology Source Type: news
CAM National Baseline ReportEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
The Department of Health has published 'CAM National... (Source: Cancer Plan Newsfeed)
Source: Cancer Plan Newsfeed - November 20, 2009 Category: Cancer & Oncology Source Type: organizations
Annual evidence update on lung cancerEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
This is the 5th Annual Evidence Update (AEU) on lung cancer... (Source: Cancer Plan Newsfeed)
Source: Cancer Plan Newsfeed - November 20, 2009 Category: Cancer & Oncology Source Type: organizations
Manual for Cancer Services 2008: Children’s Cancer MeasuresEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Following a three month consultation period , this is the... (Source: Cancer Plan Newsfeed)
Source: Cancer Plan Newsfeed - November 20, 2009 Category: Cancer & Oncology Source Type: organizations
Experts contest review article declaring breast MRI causes more harm than good by encouraging radical RxEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
A review article asserting breast MRI does not improve surgical planning, reduce follow-up surgeries, or reduce the risk of local recurrences drew the ire of the breast imaging community. (Source: Cancer Network)
Source: Cancer Network - November 20, 2009 Category: Cancer & Oncology Source Type: info
Is Type 2 Diabetes Mellitus A Risk Factor For Gallbladder, Biliary And Pancreatic Cancer?Email this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
There are minimal data assessing the relationship between diabetes and gallbladder, biliary and pancreatic cancer. Recent small studies have suggested an elevated risk of pancreatic cancer only in patients with diabetes mellitus (DM). A research article published on November 14, 2009 in the World Journal of Gastroenterology addresses this question. The research team, lead by Dr. (Source: Cancer / Oncology News From Medical News Today)
Source: Cancer / Oncology News From Medical News Today - November 20, 2009 Category: Cancer & Oncology Tags: Diabetes Source Type: news
JAMA article reignites debate over screeningEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
In a prepared statement, Dr. Brawley said the ACS stands by its recommendation that women 40 years and older should receive annual mammography screening, and women at high risk should talk with their doctors about when screening should begin based on their family history. (Source: Cancer Network)
Source: Cancer Network - November 20, 2009 Category: Cancer & Oncology Source Type: info
Ultrasound targets lymph node recurrence in breast cancerEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Ultrasound is an effective way to monitor lymph node recurrence after breast cancer surgery, South Korean researchers reported. Regional lymph node recurrence affects just 2% to 16% of patients with any stage of breast cancer, but is difficult to manage and associated with poor prognosis. (Source: Cancer Network)
Source: Cancer Network - November 20, 2009 Category: Cancer & Oncology Source Type: info
Insurers Say They Won't Alter Mammogram Coverage Despite New GuidelinesEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Insurance companies say mammogram coverage is unlikely to change despite the debate over the effectiveness of breast cancer screenings for women in their forties. (Source: Breast Cancer News From Medical News Today)
Source: Breast Cancer News From Medical News Today - November 20, 2009 Category: Cancer & Oncology Tags: Breast Cancer Source Type: news
Columnists, Rep. Stupak Comment On Abortion Restrictions In House Health Reform BillEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Several newspapers recently published opinion pieces regarding an amendment sponsored by Reps. Bart Stupak's (D-Mich.) and Joe Pitts (R-Pa.) to the House health care reform bill (HR 3962) that would prohibit abortion coverage in private and public health plans that receive federal subsidies. Summaries appear below. (Source: Breast Cancer News From Medical News Today)
Source: Breast Cancer News From Medical News Today - November 20, 2009 Category: Cancer & Oncology Tags: Abortion Source Type: news
HHS Sec. Sebelius Says New Mammogram Guidelines Will Not Change Federal PoliciesEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
HHS Secretary Kathleen Sebelius on Wednesday said that federal health insurance programs will not alter their mammogram coverage policies following new recommendations from the U.S. Preventive Services Task Force, the New York Times reports. The guidelines, (Source: Breast Cancer News From Medical News Today)
Source: Breast Cancer News From Medical News Today - November 20, 2009 Category: Cancer & Oncology Tags: Breast Cancer Source Type: news
NICE Appraisal Of Sorafenib For Advanced Hepatocellular CarcinomaEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
The National Institute for Health and Clinical Excellence (NICE) is currently appraising the use of sorafenib for advanced hepatocellular carcinoma (HCC) in patients for whom surgery or therapies in the region the cancer arose have failed or are not suitable. In its latest draft guidance, published yesterday (19 November 2009), NICE does not recommend sorafenib. (Source: Cancer / Oncology News From Medical News Today)
Source: Cancer / Oncology News From Medical News Today - November 20, 2009 Category: Cancer & Oncology Tags: Cancer / Oncology Source Type: news
Esteemed Endorsements Recognize Promising Future Of Breast-Specific Gamma Imaging (BSGI)Email this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Breast-Specific Gamma Imaging/Molecular Breast Imaging (BSGI/MBI) has been recognized and endorsed by two highly esteemed organizations for the fight against breast cancer: The Society of Breast Imaging (SBI) and the American College of Surgeons. Both societies published articles supporting the further application of this breakthrough imaging technology for the early detection of breast cancer. (Source: Breast Cancer News From Medical News Today)
Source: Breast Cancer News From Medical News Today - November 20, 2009 Category: Cancer & Oncology Tags: Breast Cancer Source Type: news
Adding capecitabine to gemcitabine improved survival, response in pancreatic cancerEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
(Source: HemOncToday.com)
Source: HemOncToday.com - November 20, 2009 Category: Cancer & Oncology Source Type: info
New Cancer Research Tool: Roche's CIM-Plate 16 Enables Real-Time Analysis Of Cell Migration On The XCELLigence SystemEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Roche Applied Science announces the availability of the new CIM-Plate 16 for their xCELLigence System for cell analysis, for use in cancer research. The 16-well culture plate features electronic sensors for the direct study of cell migration and invasion on the xCELLigence RTCA DP Instrument. (Source: Cancer / Oncology News From Medical News Today)
Source: Cancer / Oncology News From Medical News Today - November 20, 2009 Category: Cancer & Oncology Tags: Cancer / Oncology Source Type: news
Alnylam Presents New Pre-clinical Data On ALN-VSP, An RNAi Therapeutic For The Treatment Of Liver CancerEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), a leading RNAi therapeutics company, announced new pre-clinical data from its ALN-VSP program presented at the AACR-NCI-EORTC Molecular Targets and Cancer Therapeutics International conference being held November 15 - 19, 2009 in Boston, Mass. ALN-VSP is an RNAi therapeutic currently in a Phase I clinical trial for the treatment of liver cancers, including hepatocellular carcinoma (HCC) and other solid tumors with liver involvement. (Source: Cancer / Oncology News From Medical News Today)
Source: Cancer / Oncology News From Medical News Today - November 20, 2009 Category: Cancer & Oncology Tags: Liver Disease / Hepatitis Source Type: news
Treatment With Folic Acid, Vitamin B12 Associated With Increased Risk Of Cancer, DeathEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Patients with heart disease in Norway, a country with no fortification of foods with folic acid, had an associated increased risk of cancer and death from any cause if they had received treatment with folic acid and vitamin B12, according to a study in the November 18 issue of JAMA. (Source: Cancer / Oncology News From Medical News Today)
Source: Cancer / Oncology News From Medical News Today - November 20, 2009 Category: Cancer & Oncology Tags: Cancer / Oncology Source Type: news
'Chemofog' Takes Toll On Cancer Patients, AustraliaEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
A condition that affects the memory and concentration of cancer patients undergoing chemotherapy is sustained in a subgroup of patients, compromising their ability to function and long-term quality of life, according to research presented on wednesday at a major cancer conference. (Source: Cancer / Oncology News From Medical News Today)
Source: Cancer / Oncology News From Medical News Today - November 20, 2009 Category: Cancer & Oncology Tags: Cancer / Oncology Source Type: news
What Is Laryngeal Cancer (Cancer Of The Larynx)? What Causes Laryngeal Cancer?Email this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Laryngeal cancer (cancer of the larynx) is a rare type of cancer. It can cause hoarseness of the voice and swelling of the throat. The larynx, also known as the voice box, is a tube-like structure found at the entrance of the trachea (windpipe). The lump at the front of the throat, commonly known as the Adam's apple, is the larynx. (Source: Cancer / Oncology News From Medical News Today)
Source: Cancer / Oncology News From Medical News Today - November 20, 2009 Category: Cancer & Oncology Tags: Cancer / Oncology Source Type: news
New Toxicity Testing Approach Could Make Chemo Drugs SaferEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
For cancer patients on chemotherapy, the "cure" can be as deadly as the disease itself. Adverse drug reactions are one of the leading causes of death among patients receiving cancer treatment. Jackson Laboratory Professor Gary Churchill wants to change that. With a new two-year, $1 million grant from the National Cancer Institute, Churchill is launching a radical new approach to testing three chemotherapeutic drugs for potential toxic effects. (Source: Cancer / Oncology News From Medical News Today)
Source: Cancer / Oncology News From Medical News Today - November 20, 2009 Category: Cancer & Oncology Tags: Cancer / Oncology Source Type: news
Cancers' Sweet Tooth May Be WeaknessEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
The pedal-to-the-metal signals driving the growth of several types of cancer cells lead to a common switch governing the use of glucose, researchers at Winship Cancer Institute of Emory University have discovered. Scientists who study cancer have known for decades that cancer cells tend to consume more glucose, or blood sugar, than healthy cells. (Source: Cancer / Oncology News From Medical News Today)
Source: Cancer / Oncology News From Medical News Today - November 20, 2009 Category: Cancer & Oncology Tags: Cancer / Oncology Source Type: news
'Fly Paper' To Capture Circulating Cancer CellsEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Just as fly paper captures insects, an innovative new device with nano-sized features developed by researchers at UCLA is able to grab cancer cells in the blood that have broken off from a tumor. These cells, known as circulating tumor cells, or CTCs, can provide critical information for examining and diagnosing cancer metastasis, determining patient prognosis, and monitoring the effectiveness of therapies. (Source: Cancer / Oncology News From Medical News Today)
Source: Cancer / Oncology News From Medical News Today - November 20, 2009 Category: Cancer & Oncology Tags: Cancer / Oncology Source Type: news
New Pap Test Guidelines: Start Later, Have FewerEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Title: New Pap Test Guidelines: Start Later, Have FewerCategory: Health NewsCreated: 11/20/2009 8:10:00 AMLast Editorial Review: 11/20/2009 (Source: MedicineNet Cancer General)
Source: MedicineNet Cancer General - November 20, 2009 Category: Cancer & Oncology Source Type: consumer
Too Few Older Adults Get Recommended ScreeningsEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Title: Too Few Older Adults Get Recommended ScreeningsCategory: Health NewsCreated: 11/19/2009 10:10:00 PMLast Editorial Review: 11/20/2009 (Source: MedicineNet Cancer General)
Source: MedicineNet Cancer General - November 20, 2009 Category: Cancer & Oncology Source Type: consumer
Task Force Member Defends Mammography GuidelinesEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Title: Task Force Member Defends Mammography GuidelinesCategory: Health NewsCreated: 11/19/2009 12:10:00 PMLast Editorial Review: 11/20/2009 (Source: MedicineNet Cancer General)
Source: MedicineNet Cancer General - November 20, 2009 Category: Cancer & Oncology Source Type: consumer
